The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The stem cell market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 9%, as per The Business Research Company’s market report!

Read More On The Stem Cell Market Report 2022 – https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

The Stem Cell Market Size In 2022 And Forecast

The global stem cell market is expected to grow from $11.59 billion in 2021 to $12.72 billion in 2022 at a compound annual growth rate (CAGR) of 9.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The stem cell market market is expected to reach $18.51 billion in 2026 at a CAGR of 9.8%.

The stem cell market consists of sales of stem cells products such as human embryonic stem cell, induced pluripotent stem cell and adult stem cell.

Request for A Sample Of The Global Stem Cell Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2584&type=smp

An Increase In The Prevalence Of Chronic Diseases Worldwide Is Driving The Growth Of The Stem Cell Market

According to WHO, in 2020, prevalence of chronic disease increased to 57%. As the prevalence of chronic disease increases, people opting for the stem cell-based treatment will rise, thus driving the market going forward. Currently, approximately 26,000 patients are treated with blood stem cells in Europe each year.

Competitive Landscape And The Regional Analysis Of The Stem Cell Market

Major players in the stem cell market are Anterogen Co., Ltd, Mesoblast Ltd, Osiris TherapeuticsInc, AlloSource, Cellular Engineering Technologies, BIOTIMEInc, Astellas Pharma USInc, Vericel, RTI SurgicalInc and Takara Bio Company.

The Stem Cell Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the stem cell market.

Development Of New Technologies – A Key Trend In The Stem Cell Market

Companies in the stem cell therapeutics market are focusing on development of new technologies such as the Induced Pluripotent Stem Cells (IPSC) to boost the efficiency of stem cell therapies. IPSC are obtained from blood or skin cells that are reprogrammed to an embryonic-like pluripotent state by incorporating genes that are essential for maintaining key properties and growth of an unlimited source of any kind of human cell required for stem cell therapeutic purposes. These IPSC’s are not derived from human embryos, which removes the bioethical issues, thus allowing scientists to obtain federal funding and support easily.

Stem Cell Market Segmentation By The Business Research Company

1) By Source: Autologous, Allogeneic

2) By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Others

3) By Application: Regenerative Medicine, Drug Discovery And Development

Here Are Some Reports Related To The Stem Cell Market –

Cell Therapy Global Market Report 2022

Gene Therapy Global Market Report 2022

Microbiome Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: